BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Other News

IntelGenx, Valeant Pharmaceuticals neurology news

The U.S. District Court for the District of Delaware ruled in favor of IntelGenx in a patent infringement suit under which Biovail Corp. alleged that IntelGenx's

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >